[1]Meeks J J, Zhao L C, Cashy J, et al. Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program[J]. BJU Int, 2012, 109(6): 831
[2]Mikuz G. Histologic classification of prostate cancer[J]. Anal Quant Cytopathol Histopathol , 2015, 37(1): 39
[3]Grignon D J. Unusual subtypes of prostate Cancer[J]. Mod Pathol, 2004, 17(3): 316
[4]Shazer R L, Luthringer D, Agus D B, et al. Ductal adenocarcinoma of the prostate[J]. Clin Adv Hematol Oncol, 2004, 2(6): 393
[5]Morgan T M, Welty C J, Vakar-Lopez F, et al. Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen[J]. J Urol, 2010, 184(6): 2303
[6]Siegel R, Ma Jie MIN, Zou Zhao HUI, et al. Cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(1): 9
[7]Ferlay J, Shin H R, Bray F, et al. Estimates of worldwide burden of Cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893
[8]Christensen W N, Steinberg G, Walsh P C, et al. Prostatic duct adenocarcinoma. Findings at radical prostatectomy[J]. Cancer, 1991, 67(8): 2118
[9]Zhao Tao, Liao Banghua, Yao Jin, et al. Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer[J]. Prostate, 2015, 75(3): 225
[10]Herawi M, Epstein J I. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate[J]. Am J Surg Pathol, 2007, 31(6): 889
[11]Leite K R, Mitteldorf C A, Srougi M, et al. Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate Cancer[J]. Ann Diagn Pathol, 2008, 12(4): 260
[12]Jiang X, Zhu S, Feng G, et al. Is an initial saturation prostate biopsy scheme better than an extended scheme for detection of prostate cancer. A systematic review and meta-analysis[J].Eur Urol, 2013, 63(6): 1031
[13]薛健,梁磊,姜文弟,等.经会阴饱和穿刺与传统前列腺穿刺活检法诊断前列腺癌对比分析[J].天津医药,2013,41(9):920
[14]Eade T N, Al-Saleem T, Horwitz E M, et al. Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate[J]. Cancer, 2007, 109(10): 2011
[15]Van der Kwast T, Al Daoud N, Collette L, et al. Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate Cancer patients treated by radiotherapy[J]. Eur J Cancer, 2012, 48(9): 1318
[16]Kimura K, Tsuzuki T, Kato M, et al. Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens[J]. Prostate, 2014, 74(6): 680
[17]Aydin H, Zhang J, Samaratunga H, et al. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease:implications for clinical management[J]. BJU Int, 2010, 105(4): 476.
[18]Tu S M, Lopez A, Leibovici D, et al. Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy[J]. Cancer, 2009, 115(13): 2872
[19]Samaratunga H, Duffy D, Yaxley J, et al. Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension[J]. Hum Pathol, 2010, 41(2): 281
[1]吴值荣,高超.核磁定量参数联合听性脑干反应对ASD的诊断价值[J].天津医科大学学报,2023,29(02):174.
WU Zhi-rong,GAO Chao.Diagnostic value of MRI quantitative parameters combined with auditory brainstem response in ASD[J].Journal of Tianjin Medical University,2023,29(02):174.
[2]陈静综述,高桦审校.原发性自身免疫性垂体炎的诊断研究进展[J].天津医科大学学报,2023,29(02):223.
基金项目 天津市科技计划项目基金资助(11ZCGYSY02300)
作者简介 李鹏昊(1988 -),男,硕士在读,研究方向:泌尿外科;通信作者:张志宏,E—mail:zhihongzhang1967@163.com。
?